ENTO
Price
$0.62
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
IMMP
Price
$1.98
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
14 days until earnings call
Ad is loading...

ENTO vs IMMP

Header iconENTO vs IMMP Comparison
Open Charts ENTO vs IMMPBanner chart's image
Entero Therapeutics
Price$0.62
Change-$0.00 (-0.00%)
Volume$46K
CapitalizationN/A
Immutep
Price$1.98
Change-$0.00 (-0.00%)
Volume$99.05K
CapitalizationN/A
ENTO vs IMMP Comparison Chart
Loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ENTO vs. IMMP commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTO is a StrongSell and IMMP is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (ENTO: $0.62 vs. IMMP: $1.98)
Brand notoriety: ENTO and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTO: 10% vs. IMMP: 95%
Market capitalization -- ENTO: $3M vs. IMMP: $294.41M
ENTO [@Biotechnology] is valued at $3M. IMMP’s [@Biotechnology] market capitalization is $294.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTO’s FA Score shows that 1 FA rating(s) are green whileIMMP’s FA Score has 0 green FA rating(s).

  • ENTO’s FA Score: 1 green, 4 red.
  • IMMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTO is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTO’s TA Score shows that 4 TA indicator(s) are bullish while IMMP’s TA Score has 6 bullish TA indicator(s).

  • ENTO’s TA Score: 4 bullish, 5 bearish.
  • IMMP’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, IMMP is a better buy in the short-term than ENTO.

Price Growth

ENTO (@Biotechnology) experienced а -13.04% price change this week, while IMMP (@Biotechnology) price change was +8.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

IMMP is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($294M) has a higher market cap than ENTO($3M). IMMP YTD gains are higher at: -17.500 vs. ENTO (-85.238). ENTO has higher annual earnings (EBITDA): -20.9M vs. IMMP (-40.49M). ENTO (0) and IMMP (0) have equivalent revenues.
ENTOIMMPENTO / IMMP
Capitalization3M294M1%
EBITDA-20.9M-40.49M52%
Gain YTD-85.238-17.500487%
P/E Ratio0.05N/A-
Revenue00-
Total Cash11.4MN/A-
Total Debt6.98MN/A-
FUNDAMENTALS RATINGS
ENTO vs IMMP: Fundamental Ratings
ENTO
IMMP
OUTLOOK RATING
1..100
8222
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
4161
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENTO's Valuation (10) in the null industry is significantly better than the same rating for IMMP (84) in the Biotechnology industry. This means that ENTO’s stock grew significantly faster than IMMP’s over the last 12 months.

IMMP's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as ENTO (100) in the null industry. This means that IMMP’s stock grew similarly to ENTO’s over the last 12 months.

IMMP's SMR Rating (96) in the Biotechnology industry is in the same range as ENTO (97) in the null industry. This means that IMMP’s stock grew similarly to ENTO’s over the last 12 months.

ENTO's Price Growth Rating (41) in the null industry is in the same range as IMMP (61) in the Biotechnology industry. This means that ENTO’s stock grew similarly to IMMP’s over the last 12 months.

ENTO's P/E Growth Rating (79) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that ENTO’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTOIMMP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
ENTO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSAX31.77N/A
N/A
Goldman Sachs Small Cap Eq Insghts A
GSCOX29.01N/A
N/A
Goldman Sachs Small Cap Gr Insghts C
RISSX12.25N/A
N/A
RBC International Small Cap Equity A
ABCVX24.31-0.16
-0.65%
American Beacon The London Co Inc Eq Inv
HQICX22.45-0.20
-0.88%
Hartford Equity Income C

ENTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTO has been loosely correlated with IVVD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTO jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTO
1D Price
Change %
ENTO100%
-2.61%
IVVD - ENTO
60%
Loosely correlated
+0.46%
RLMD - ENTO
36%
Loosely correlated
+1.54%
CABA - ENTO
35%
Loosely correlated
-3.59%
IMMP - ENTO
29%
Poorly correlated
N/A
MEOBF - ENTO
24%
Poorly correlated
N/A
More

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
N/A
PRRUF - IMMP
43%
Loosely correlated
+10.68%
XFOR - IMMP
35%
Loosely correlated
-10.72%
ARCT - IMMP
31%
Poorly correlated
-3.98%
AXON - IMMP
31%
Poorly correlated
-3.38%
SNPX - IMMP
30%
Poorly correlated
-4.61%
More